7 articles
Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.
The startup, led by iota Biosciences founder Michel Maharbiz, is developing a minimally invasive brain-computer interface that pairs neural decoding with a motorized grip-assist glove to restore movement after stroke.
At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.
The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.
Sam Altman's brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.
The second annual forum brought together device makers, investors, and six early-stage startups for two days of panels on BCI, neuromodulation, and digital health.
Five patients now carry the coin-sized wireless implant that sits on the brain's protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.